Transmissible Diseases in Sperm Donation: Viruses, Bacteria, and Genetic Risks

Author photo
Written by Zappelphilipp MarxJune 13, 2025
Lab technician analyzing a semen sample

In the United States, over ten thousand people each year turn to sperm donation to fulfill their dream of starting a family. Modern screening methods significantly reduce health risks, but a residual risk always remains. This article explains which viruses, bacteria, parasites, and inherited disorders can be transmitted—and how multi-stage laboratory screenings minimize those risks.

Why Multi-Stage Screening Is Essential

Pathogens often go through a window period: they’re present in the donor but not yet detectable by antibody tests alone. That’s why the Centers for Disease Control and Prevention (CDC) and the American Society for Reproductive Medicine (ASRM) recommend combining serology with PCR and quarantining donor samples for several months before release.

Viruses Detectable in Ejaculate

  • HIV – ELISA and PCR testing, plus sample quarantine.
  • Hepatitis B & C – antibody and antigen assays to prevent liver damage.
  • Herpes Simplex Virus 1 & 2 – PCR testing; low risk in asymptomatic donors.
  • Cytomegalovirus (CMV) – IgG/IgM screening; critical for immunocompromised recipients.
  • Zika Virus – RT-PCR and antibody testing after travel to endemic areas.
  • HTLV I/II – rare but associated with leukemia.
  • Human Papillomavirus (HPV) – PCR for high-risk types (cervical cancer prevention).
  • West Nile & Dengue Viruses – important for donors from tropical or subtropical regions.
  • SARS-CoV-2 – included in some screening panels during peak pandemic periods.

Bacteria and Parasites in Semen

  • Chlamydia trachomatis – often asymptomatic; can impair fertility.
  • Neisseria gonorrhoeae – detected via NAAT or culture swabs.
  • Treponema pallidum (Syphilis) – mandatory TPPA and VDRL serology.
  • Urogenital Flora such as E. coli and enterococci – can cause inflammation.
  • Trichomonas vaginalis – known to reduce sperm quality.
  • Mycoplasma/Ureaplasma – often silent, yet inflammatory.

Genetic Risk Factors

  • Cystic Fibrosis – CFTR gene analysis
  • Tay-Sachs Disease – HEXA mutation screening
  • Spinal Muscular Atrophy – SMN1 gene testing
  • Sickle Cell & Thalassemia – hemoglobinopathy panels
  • Fragile X Syndrome – FMR1 gene repeat analysis
  • Y-Chromosome Microdeletions – linked to severe oligospermia
  • Gaucher Disease – relevant for Ashkenazi Jewish donors
  • Population-Specific Panels – e.g., Fanconi anemia, Wilson’s disease

Which Diseases Can Be Ruled Out?

By combining serology, PCR, genetic panels, and a multi-month quarantine, laboratories can effectively exclude all relevant viruses, bacteria, parasites, and inherited disorders—driving the residual risk to an exceptionally low level.

The Screening Process

  1. Health History – comprehensive questionnaire and counseling.
  2. Laboratory Tests – antibody, antigen, and PCR assays.
  3. Genetic Panel – screening for common hereditary conditions.
  4. Quarantine – samples stored frozen for ≥3 months.
  5. Retest – confirm absence of new infections before release.

Private Donation vs. Sperm Bank

Accredited sperm banks ensure maximum safety with regulated tests, quarantine protocols, and donor registries. Private donations offer a more personal experience and can be less expensive but require customized testing and legal agreements.

RattleStork app home screen
Figure: RattleStork – the sperm donation apps

Conclusion

Sperm donation opens the door to parenthood for many. A thorough, CDC- and ASRM-recommended screening protocol is essential to virtually eliminate the risk of infection or genetic disorder transmission. Trust accredited facilities or vetted platforms—and give your future family the safest possible start.

Frequently Asked Questions (FAQ)

With combined PCR and antibody testing, a three-month quarantine, and final retesting, the residual risk is under 0.1%.

Standard panels cover HIV, Hepatitis B/C, Syphilis, Chlamydia, Gonorrhea, CMV, HTLV, HPV, plus a genetic screening panel.

Yes. Samples are screened immediately and again after the quarantine period using ELISA and PCR.

Absolutely. HBsAg, anti-HBc, and anti-HCV assays are required by regulation.

A urine or urethral swab tested by NAAT confirms absence of Chlamydia.

Common screenings include Cystic Fibrosis, SMA, Sickle Cell/Thalassemia, Fragile X, and population-specific panels.

To bridge the window period for many pathogens; a second blood test is done before release.

In the U.S., total costs including screening typically range from $700 to $1,200 per sample.

Donors are usually 18–40 years old, in good health, STI-negative, and meet strict sperm quality standards.

No. Only licensed sperm banks follow standardized testing, quarantine, and legal safeguards.

The child has a legal right to learn the donor’s identity once they reach adulthood.

PCR swabs for high-risk HPV types; positive samples are discarded.

Zika can persist in semen for months and cause fetal defects; RT-PCR rules out this risk.

Yes. Many clinics only accept CMV-negative donors to minimize complications.

Consultation → Consent → Blood & Urine Tests → Donation → Quarantine → Retest → Release → Insemination.

Clinical pregnancy rates are about 15–20% per insemination; over three cycles, cumulative rates exceed 50%.

Yes. Any positive cultures undergo antibiotic sensitivity testing; resistant strains are excluded.

Stored in liquid nitrogen (–196 °C), semen can remain viable for decades.

Many fertility centers treat recipients up to age 45; beyond that, health risks increase significantly.

Absolutely. High sperm count and motility greatly improve fertilization chances and are verified before release.